Catalyst President Nancy Bradish Myers will moderate a panel discussion on genomics and Precision Medicine at the Drug Information Association’s annual meeting on June 17, 2015, in Washington, DC.

The panel, entitled “Precision Medicine: Where Is the Technology Taking Us, How Fast, and Who Is On Board?” will explore advances in technology, including next-generation sequencing (NGS), that are poised to enable a new era of Precision Medicine. How will the rapid rise of whole genome sequencing (WGS) and whole exome sequencing (WES) change the way we make diagnosis and treatment decisions? How will FDA’s developing approach to regulation of NGS-based tests affect innovation? Panelists representing industry, patient advocacy, researchers and regulators will debate the future of Precision Medicine and the opportunities and challenges presented by rapidly evolving technologies.